Cargando…
Development Tracks for Cancer Prevention Markers
We provide a general framework for describing various roles for biomarkers in cancer prevention research (early detection, surrogate endpoint, and cohort identification for primary prevention) and the phases in their evaluation.
Autores principales: | Baker, Stuart G., Kramer, Barnett S., Prorok, Philip C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839325/ https://www.ncbi.nlm.nih.gov/pubmed/15322317 http://dx.doi.org/10.1155/2004/309391 |
Ejemplares similares
-
Statistical issues in randomized trials of cancer screening
por: Baker, Stuart G, et al.
Publicado: (2002) -
Using observational data to estimate an upper bound on the reduction in cancer mortality due to periodic screening
por: Baker, Stuart G, et al.
Publicado: (2003) -
Comparing breast cancer mortality rates before-and-after a change in availability of screening in different regions: Extension of the paired availability design
por: Baker, Stuart G, et al.
Publicado: (2004) -
Markers for early detection of cancer: Statistical guidelines for nested case-control studies
por: Baker, Stuart G, et al.
Publicado: (2002) -
Lung cancer screening with low-dose helical CT: results from the National Lung Screening Trial (NLST)
por: Kramer, Barnett S, et al.
Publicado: (2011)